Stratos Wealth Partners’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-2,059
| Closed | -$4K | – | 960 |
|
|
2018
Q4 | $4K | Sell |
2,059
-275
| -12% | -$534 | ﹤0.01% | 876 |
|
|
2018
Q3 | $11K | Sell |
2,334
-200
| -8% | -$943 | ﹤0.01% | 2171 |
|
|
2018
Q2 | $12K | Hold |
2,534
| – | – | ﹤0.01% | 971 |
|
|
2018
Q1 | $18K | Hold |
2,534
| – | – | ﹤0.01% | 2065 |
|
|
2017
Q4 | $18K | Sell |
2,534
-230
| -8% | -$1.63K | ﹤0.01% | 1956 |
|
|
2017
Q3 | $23K | Buy |
2,764
+390
| +16% | +$3.25K | ﹤0.01% | 915 |
|
|
2017
Q2 | $24K | Hold |
2,374
| – | – | ﹤0.01% | 820 |
|
|
2017
Q1 | $27K | Buy |
2,374
+100
| +4% | +$1.14K | ﹤0.01% | 788 |
|
|
2016
Q4 | $29K | Buy |
+2,274
| New | +$29K | ﹤0.01% | 710 |
|
|
2016
Q2 | – | Sell |
-2,127
| Closed | -$40K | – | 676 |
|
|
2016
Q1 | $40K | Hold |
2,127
| – | – | ﹤0.01% | 569 |
|
|
2015
Q4 | $57K | Hold |
2,127
| – | – | ﹤0.01% | 570 |
|
|
2015
Q3 | $97K | Hold |
2,127
| – | – | 0.01% | 516 |
|
|
2015
Q2 | $68K | Hold |
2,127
| – | – | 0.01% | 509 |
|
|
2015
Q1 | $68K | Sell |
2,127
-150
| -7% | -$4.8K | 0.01% | 602 |
|
|
2014
Q4 | $86K | Hold |
2,277
| – | – | 0.02% | 489 |
|
|
2014
Q3 | $60K | Hold |
2,277
| – | – | 0.01% | 308 |
|
|
2014
Q2 | $67K | Buy |
+2,277
| New | +$67K | 0.02% | 305 |
|